Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 111.00
0.00 (0.00%)
Feb 25, 2026, 3:07 PM IST
Sotac Pharmaceuticals Revenue
Sotac Pharmaceuticals had revenue of 185.05M INR in the quarter ending September 30, 2025, a decrease of -32.33%. This brings the company's revenue in the last twelve months to 846.72M, down -19.27% year-over-year. In the fiscal year ending March 31, 2025, Sotac Pharmaceuticals had annual revenue of 1.00B, down -3.57%.
Revenue (ttm)
846.72M
Revenue Growth
-19.27%
P/S Ratio
1.45
Revenue / Employee
6.67M
Employees
127
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.00B | -37.09M | -3.57% |
| Mar 31, 2024 | 1.04B | 264.82M | 34.18% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | 488.43M | 202.40M | 70.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Accent Microcell | 2.78B |
| Infinium Pharmachem | 1.57B |
| Zenith Drugs | 1.44B |
| Quest Laboratories | 1.26B |
| Sunrest Lifescience | 520.34M |
| Medicamen Organics | 394.30M |
| Vilin Bio Med | 199.81M |